welcome to oneFAPvoice- a positively charged Familial Adenomatous Polyposis community.
- join today!
Coxib-inhibition of Duodenal Polyp Growth in FAP
study id #: NCT00844727
condition: Duodenal Polyposis
Preliminary data indicate a protective effect on the development of duodenal polyps by coxib treatment. The hypothesis of the present study is that normal therapy doses of rofecoxib for 1 year would stop or reverse the development of premalignant adenomatous lesions in the duodenal mucosa of FAP patients.
start date: September 2003
estimated completion: April 2004
last updated: July 6, 2011
phase of development: Phase 2, Phase 3
size / enrollment: 38
Intervention Model: Parallel Assignment
Primary Purpose: Treatment
- FAP patient with previous colectomy and confirmed polyposis
- NSAID hypersensitivity
expertly curated content related to this topic
Hereditary Colorectal CancerMore than one-third of adolescents and y...
Role of the Microenvironment in the Tumourigenesis of Microsatellite Unstable and MutYH-Associated Polyposis Colorec...Two forms of genomic instability can be ...
Molecular Fluorescence Endoscopy in Patients With Familial Adenomatous Polyposis, Using Bevacizumab-IRDye800CWThere is a need for better visualization...
Medscape Overview on Familial Adenomatous PolyposisFamilial adenomatous polyposis (FAP) is ...
Studies of the Foregut in Patients with Familial Adenomatous Polyposis (FAP): The Clinical Problem, Management, and ...Thirty-eight published papers, co-author...
Colon-Specific Delivery of Celecoxib is a Potential Strategy to Improve Toxicological and Pharmacological Properties...In general, colon-specific delivery of a...